CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 139 filers reported holding CRINETICS PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is 19.18 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $47,284,548 | +85.5% | 1,589,931 | +12.4% | 3.14% | +106.2% |
| Q2 2023 | $25,495,110 | +12.2% | 1,414,823 | 0.0% | 1.52% | -7.4% |
| Q1 2023 | $22,722,057 | -12.2% | 1,414,823 | 0.0% | 1.64% | +2.2% |
| Q4 2022 | $25,891,261 | -6.8% | 1,414,823 | 0.0% | 1.61% | -24.8% |
| Q3 2022 | $27,787,000 | +5.3% | 1,414,823 | 0.0% | 2.14% | -14.1% |
| Q2 2022 | $26,386,000 | -15.0% | 1,414,823 | 0.0% | 2.49% | -5.9% |
| Q1 2022 | $31,055,000 | – | 1,414,823 | – | 2.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 3,375,169 | $76,819,000 | 7.66% |
| RA Capital Management | 1,875,209 | $42,680,000 | 1.84% |
| Perceptive Advisors | 2,587,953 | $58,901,000 | 1.66% |
| EMORY UNIVERSITY | 97,035 | $2,209,000 | 1.55% |
| New Leaf Venture Partners, L.L.C. | 167,700 | $3,817,000 | 1.05% |
| Orbimed Advisors | 1,914,282 | $43,569,000 | 0.67% |
| Opaleye Management Inc. | 73,000 | $1,661,000 | 0.46% |
| Novo Holdings A/S | 135,009 | $3,073,000 | 0.46% |
| Virtus ETF Advisers LLC | 7,934 | $181,000 | 0.38% |
| Eventide Asset Management | 384,000 | $8,740,000 | 0.30% |